futibatinib
otsuka
['foenix-cca2', 'futibatinib']
up next at #asco22, grantee lipika goyal, md, shares updated results from the foenix-cca2 trial: "efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (icca) harboring fgfr2 fusions/rearrangements."
Follow us for updates on the latest American Cancer Society research to help prevent, fight and cure cancer. 
https://t.co/Y9sAPyOasI